Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab.

ABSTRACT:

SUBMITTER: Blauvelt A 

PROVIDER: S-EPMC9558055 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature